These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 8393521

  • 1. The extracellular disulfide loop motif of the inhibitory glycine receptor does not form the agonist binding site.
    Vandenberg RJ, Rajendra S, French CR, Barry PH, Schofield PR.
    Mol Pharmacol; 1993 Jul; 44(1):198-203. PubMed ID: 8393521
    [Abstract] [Full Text] [Related]

  • 2. Identification of a new ligand binding domain in the alpha1 subunit of the inhibitory glycine receptor.
    Vafa B, Lewis TM, Cunningham AM, Jacques P, Lynch JW, Schofield PR.
    J Neurochem; 1999 Nov; 73(5):2158-66. PubMed ID: 10537076
    [Abstract] [Full Text] [Related]

  • 3. The agonist binding site of the gamma-aminobutyric acid type A channel is not formed by the extracellular cysteine loop.
    Amin J, Dickerson IM, Weiss DS.
    Mol Pharmacol; 1994 Feb; 45(2):317-23. PubMed ID: 7509443
    [Abstract] [Full Text] [Related]

  • 4. Alanine-scanning mutagenesis in the signature disulfide loop of the glycine receptor alpha 1 subunit: critical residues for activation and modulation.
    Schofield CM, Trudell JR, Harrison NL.
    Biochemistry; 2004 Aug 10; 43(31):10058-63. PubMed ID: 15287733
    [Abstract] [Full Text] [Related]

  • 5. Modeling of agonist binding to the ligand-gated ion channel superfamily of receptors.
    Cockcroft VB, Osguthorpe DJ, Barnard EA, Lunt GG.
    Proteins; 1990 Aug 10; 8(4):386-97. PubMed ID: 1965333
    [Abstract] [Full Text] [Related]

  • 6. Antagonism of ligand-gated ion channel receptors: two domains of the glycine receptor alpha subunit form the strychnine-binding site.
    Vandenberg RJ, French CR, Barry PH, Shine J, Schofield PR.
    Proc Natl Acad Sci U S A; 1992 Mar 01; 89(5):1765-9. PubMed ID: 1311851
    [Abstract] [Full Text] [Related]

  • 7. Effects of a mutation in the TM2-TM3 linker region of the glycine receptor alpha1 subunit on gating and allosteric modulation.
    Dupre ML, Broyles JM, Mihic SJ.
    Brain Res; 2007 Jun 04; 1152():1-9. PubMed ID: 17434460
    [Abstract] [Full Text] [Related]

  • 8. Anion regulation of [3H]strychnine binding to glycine-gated chloride channels is explained by the presence of two anion binding sites.
    Marvizón JC, Skolnick P.
    Mol Pharmacol; 1988 Dec 04; 34(6):806-13. PubMed ID: 2849048
    [Abstract] [Full Text] [Related]

  • 9. Structural requirements for activation of the glycine coagonist site of N-methyl-D-aspartate receptors expressed in Xenopus oocytes.
    McBain CJ, Kleckner NW, Wyrick S, Dingledine R.
    Mol Pharmacol; 1989 Oct 04; 36(4):556-65. PubMed ID: 2554111
    [Abstract] [Full Text] [Related]

  • 10. The strychnine-binding subunit of the glycine receptor shows homology with nicotinic acetylcholine receptors.
    Grenningloh G, Rienitz A, Schmitt B, Methfessel C, Zensen M, Beyreuther K, Gundelfinger ED, Betz H.
    Nature; 1989 Oct 04; 328(6127):215-20. PubMed ID: 3037383
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA, Doufexis M, Kapas S, Chhajlani V.
    Biochem Biophys Res Commun; 2001 Mar 09; 281(4):851-7. PubMed ID: 11237737
    [Abstract] [Full Text] [Related]

  • 13. Extrinsic factors regulate partial agonist efficacy of strychnine-sensitive glycine receptors.
    Farroni JS, McCool BA.
    BMC Pharmacol; 2004 Aug 09; 4():16. PubMed ID: 15301692
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor.
    Timossi C, Ortiz-Elizondo C, Pineda DB, Dias JA, Conn PM, Ulloa-Aguirre A.
    Mol Cell Endocrinol; 2004 Aug 31; 223(1-2):17-26. PubMed ID: 15279907
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.